<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>My Ephemerae &#187; Multiple Sclerosis</title>
	<atom:link href="http://www.MyEphemerae.com/category/multiple-sclerosis/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.MyEphemerae.com</link>
	<description>Random Thoughts from James S. Huggins</description>
	<lastBuildDate>Sun, 27 Jun 2010 18:02:01 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
		<item>
		<title>Notice of a Multiple Sclerosis Research Study</title>
		<link>http://www.MyEphemerae.com/notice-of-a-multiple-sclerosis-research-study/</link>
		<comments>http://www.MyEphemerae.com/notice-of-a-multiple-sclerosis-research-study/#comments</comments>
		<pubDate>Thu, 12 Feb 2009 14:51:42 +0000</pubDate>
		<dc:creator>James S. Huggins</dc:creator>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>

		<guid isPermaLink="false">http://www.MyEphemerae.com/?p=428</guid>
		<description><![CDATA[Dear James, My name is Ashley Toal, and I work in Patient Advocacy at MediciGlobal.  We’re working on a multiple sclerosis clinical research study assessing the safety and effectiveness of an oral investigational study medication, teriflunomide.  We’d love your help in informing the MS community about this study.  Since your blog is so influential in [...]]]></description>
			<content:encoded><![CDATA[<p>Dear James,</p>
<p>My name is Ashley Toal, and I work in Patient Advocacy at MediciGlobal.  We’re working on a multiple sclerosis clinical research study assessing the safety and effectiveness of an oral investigational study medication, teriflunomide.  We’d love your help in informing the MS community about this study.  Since your blog is so influential in the MS community, would it be possible to post the below study information (in blue) on your blog? </p>
<p>Information about this study is also listed on a number of MS advocacy group websites including the National MS Society, MS Foundation and the Consortium of MS Centers.  I hope that you can also help us inform you MS blogging community about the study.  Please feel free to call or email me with any questions.</p>
<p>Best,</p>
<p>Ashley</p>
<p>Ashley Toal<br />
MediciGlobal<br />
1014 West 9th Avenue<br />
King of Prussia, PA 19406<br />
(P) 484-674-6873</p>
<p><a href="mailto:atoal@mediciglobal.com">atoal@mediciglobal.com</a><br />
<a title="Their website" href="http://www.mediciglobal.com" target="_blank">www.mediciglobal.com</a></p>
<p><strong><em>A Clinical Research Study Evaluating An Investigational Medication for Relapsing Forms of Multiple Sclerosis</em></strong></p>
<p><em>Medical researchers are enrolling people in a worldwide clinical research study for people with relapsing forms of multiple sclerosis (RMS). This study will assess the safety and effectiveness of an investigational study medication versus placebo (an inactive substance which contains no active medication) in people ages 18-55 years old with RMS.</em></p>
<p><em>The investigational medication used in this study is called teriflunomide (ter-i-flün-ō-mïde). It is derived from leflunomide (le-flü-nō-mïde), also known as Arava®. Arava® is already approved in many countries for the treatment of rheumatoid arthritis, another autoimmune disease.  </em></p>
<p><em> The first step in determining eligibility for this study is to take the pre-screening questionnaire either online or on the phone. You will be asked a series of questions related to your health and be given additional information about study site locations.  Visit </em><a title="study information" href="http://www.tower3.msstudies.com" target="_blank"><em>www.tower3.msstudies.com</em></a><em> or call 1-866-565-0245 today to learn more about the study and see if you may qualify.</em></p>
<p><strong>NB: Although I do not have MS, MS was a factor in my father&#8217;s death and my grandmother&#8217;s death. For that reason I have a section on my website for MS. You can see it here: </strong><a title="The section on my website for MS" href="http://JSH.us/ms" target="_blank"><strong>http://JSH.us/ms</strong></a><strong>.<br />
</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.MyEphemerae.com/notice-of-a-multiple-sclerosis-research-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A New Redhead I&#8217;ve Met</title>
		<link>http://www.MyEphemerae.com/a-new-redhead-ive-met/</link>
		<comments>http://www.MyEphemerae.com/a-new-redhead-ive-met/#comments</comments>
		<pubDate>Mon, 17 Dec 2007 00:46:43 +0000</pubDate>
		<dc:creator>James S. Huggins</dc:creator>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Personal Interest]]></category>

		<guid isPermaLink="false">http://www.MyEphemerae.com/a-new-redhead-ive-met/</guid>
		<description><![CDATA[Today, Kimberly A. Fabrizio wrote me. She has a Multiple Sclerosis blog (sunshineandmoonlight.wordpress.com) and wanted me to list her blog on my directory of MS websites in the MS section of my website (JSH.us/MS). I went to check it out and it clearly qualified and I quickly added it. But then, as I continued to [...]]]></description>
			<content:encoded><![CDATA[<p>Today, Kimberly A. Fabrizio wrote me. She has a Multiple Sclerosis blog (<a target="_blank" href="http://sunshineandmoonlight.wordpress.com" title="Kimberly A. Fabrizio's Multiple Sclerosis Blog">sunshineandmoonlight.wordpress.com</a>) and wanted me to list her blog on my directory of MS websites in the MS section of my website (<a target="_blank" href="http://JSH.us/MS" title="The MS Section of My Website">JSH.us/MS</a>).</p>
<p>I went to check it out and it clearly qualified and I quickly added it.</p>
<p>But then, as I continued to explore it, I discovered a <em><strong>new</strong></em> blog. Kimberly&#8217;s blog is <em><strong>very</strong></em> new, just started in Dec 2007. It is telling her new story of her discovery she has MS and her personal work to deal with this.</p>
<p>It is not very often I am privileged to discover a new blog.</p>
<p>Kimberly&#8217;s writing style is open and sharing. She lets you feel what she is feeling as she deals with this new fact in her personal life.</p>
<p>I&#8217;ve subscribed to updates using FeedBlitz. I&#8217;ll be tracking it every time she updates it.</p>
<p>Oh, and Kimberly is a red head! I love red heads!</p>
]]></content:encoded>
			<wfw:commentRss>http://www.MyEphemerae.com/a-new-redhead-ive-met/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>
